| Haber: |
Covid Vaccines May Become a Viable Business. That’s a Problem
Demand for booster shots and delta’s infectiousness have made manufacturing shots a good opportunity for the pharmaceutical industry. Where does that leave the rest of the world?
https://www.washingtonpost.com/business/covid-vaccines-may-becomea-viable-business-thats-a-problem/2021/08/31/f92233d6-0aaf-11ec-a7c8-61bb7b3bf628_story.html?utm_source=rss&utm_medium=referral&utm_campaign=wp_business
|
